Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 liquidated — weigh against the wins.
1 vehicle on file, newest listing first
Richard Emmitt ​ ​ ​ ​ 76 ​ ​ ​ Chairman and Director ​ Gerry Brunk ​ ​ ​ ​ 53 ​ ​ ​ President and Director ​ Daniel Hetu ​ ​ ​ ​ 63 ​ ​ ​ Executive Vice President ​ Vasco Larcina ​ ​ ​ ​ 56 ​ ​ ​ Chief Financial Officer ​ Peter van der Velden ​ ​ ​ ​ 60 ​ ​ ​ Director ​ Fritz A. LaPorte ​ ​ ​ ​ 51 ​ ​ ​ Director ​ Anthony “Tony” Natale, MD, MBA, our Chief Executive Officer and a Director, has over 20 years of experience in healthcare venture capital and MedTech entrepreneurship as a physician, inventor, founder, operator, and investor. As a Managing Partner at Aperture Venture Partners since 2010, Dr. Natale focuses on identifying and investing in high-potential MedTech companies.
This record is keyed to SEC CIK 0001083927 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 27 institutional-holder rows on these vehicles, under 14 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.